Back

Real-life experience with rilonacept for the treatment of recurrent pericarditis

31 August 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Acute and chronic pericarditis: how to best manage your patients Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Michele Golino

University of Florida College of Medicine – Jacksonville, Jacksonville (United States of America)

9 More presentations in this session

Presentation thumbnail
A novel risk-stratification model that predicts long-term clinical outcomes in patients with recurrent pericarditis
Doctor A. Kumar (Washington, DC, US)
Abstract Slides Video
Presentation thumbnail
Whole exome sequencing in patients with recurrent pericarditis
Doctor V. Collini (Udine, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic factors and etiological insights in constrictive pericarditis
Doctor L. Admella Severiano (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Short-pulse of systemic steroids in acute pericarditis: an alternative in refractory cases
Doctor A. Sanchez Arjona (Majadahonda, ES)
Abstract Slides Video
Presentation thumbnail
Increased adoption of IL-1 pathway inhibition and the steroid-sparing paradigm shift: temporal trends in recurrent pericarditis treatment from the RESONANCE patient registry
Doctor P. Cremer (Chicago, US)
Abstract Slides Video

Access the full session

Session thumbnail
Acute and chronic pericarditis: how to best manage your patients

The Event

Event poster

ESC Congress 2024

31 August 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Rilonacept as monotherapy for long-term recurrent pericarditis management: sustained disease control over three years
thumbnail
Congress Presentation
Multi-year recurrent pericarditis disease duration in Italian patients: clinical outcomes after cessation of long-term IL-1 pathway inhibition provide insights for chronic management
thumbnail
Congress Presentation
Rilonacept reduces pericarditis recurrence risk: clinical outcomes from the RESONANCE patient registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources